Presently, Martin H. Huber is President, Chief Executive Officer & Director at Mersana Therapeutics, Inc.

He is also on the board of Syndax Pharmaceuticals, Inc.

He previously was President, Head-Research & Development at Xilio Therapeutics, Inc., Senior Vice President-Clinical at GSK Plc and Chief Medical Officer & Senior Vice President for Tesaro, Inc. (a subsidiary of GSK Plc), Vice President-Global Pharmacovigilance at Schering-Plough Corp., Vice President-Oncology Clinical Research at Merck Research Laboratories Massachusetts LLC and Assistant Professor at The University of Texas M.D. Anderson Cancer Center.

Dr. Huber received a doctorate from Baylor College of Medicine and an undergraduate degree from Texas Lutheran University.